This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2003 Sep;122(5):718-27.

doi: 10.1046/j.1365-2141.2003.04541.x.

A selective history of the therapy of Hodgkin's disease

Vincent T DeVita Jr¹

Affiliations

PMID: 12930382
DOI: 10.1046/j.1365-2141.2003.04541.x

A selective history of the therapy of Hodgkin's disease

Vincent T DeVita Jr. Br J Haematol. 2003 Sep.

. 2003 Sep;122(5):718-27.

doi: 10.1046/j.1365-2141.2003.04541.x.

Author

Vincent T DeVita Jr¹

Affiliation

¹ Yale Cancer Center, Yale University School of Medicine, Yale-New Haven Hospital, 333 Cedar Street, New Haven, CT 06520, USA. Vincent.devita@yale.edu

PMID: 12930382
DOI: 10.1046/j.1365-2141.2003.04541.x

No abstract available

PubMed Disclaimer

Similar articles

Hodgkin's disease--from pathology specimen to cure.
Diehl V. Diehl V. N Engl J Med. 2007 Nov 8;357(19):1968-71. doi: 10.1056/NEJMe078173. N Engl J Med. 2007. PMID: 17989391 No abstract available.
Hodgkin's disease: a model for interdisciplinary cancer management: 2002 Janeway lecture.
Hoppe RT. Hoppe RT. Cancer J. 2002 Nov-Dec;8(6):425-31. doi: 10.1097/00130404-200211000-00003. Cancer J. 2002. PMID: 12500848 No abstract available.
Management of stage I and II Hodgkin's disease.
Farah R, Weichselbaum RR. Farah R, et al. Hematol Oncol Clin North Am. 1989 Jun;3(2):253-63. Hematol Oncol Clin North Am. 1989. PMID: 2663826 Review.
[Successful neoplasm chemotherapy. Remission of Hodgkin's disease. V].
Lopez M. Lopez M. Clin Ter. 2001 Sep-Oct;152(5):323-8. Clin Ter. 2001. PMID: 11794854 Italian. No abstract available.
Twenty-five years clinical trials of the German Hodgkin Study Group (GHSG).
Behringer K, Diehl V. Behringer K, et al. Eur J Haematol Suppl. 2005 Jul;(66):21-5. doi: 10.1111/j.1600-0609.2005.00450.x. Eur J Haematol Suppl. 2005. PMID: 16007864 Review.

See all similar articles

Cited by

The results of Hodgkin lymphoma treatment in children in the period 1997-2006.
Hasanbegović E, Sabanović S. Hasanbegović E, et al. Bosn J Basic Med Sci. 2008 Feb;8(1):72-5. doi: 10.17305/bjbms.2008.3001. Bosn J Basic Med Sci. 2008. PMID: 18318676 Free PMC article.
Comparison of Ifosfamide, Carboplatin and Etoposide versus Etoposide, Steroid, and Cytarabine Cisplatin as Salvage Chemotherapy in Patients with Refractory or Relapsed Hodgkin's lymphoma.
Mehrzad V, Ashrafi F, Farrashi AR, Pourmarjani R, Dehghani M, Shahsanaei A. Mehrzad V, et al. Adv Biomed Res. 2017 Mar 7;6:30. doi: 10.4103/2277-9175.201687. eCollection 2017. Adv Biomed Res. 2017. PMID: 28401077 Free PMC article.
DNA methylation patterns of adult survivors of adolescent/young adult Hodgkin lymphoma compared to their unaffected monozygotic twin.
Wang J, Van Den Berg D, Hwang AE, Weisenberger D, Triche T, Nathwani BN, Conti DV, Siegmund K, Mack TM, Horvath S, Cozen W. Wang J, et al. Leuk Lymphoma. 2019 Jun;60(6):1429-1437. doi: 10.1080/10428194.2018.1533128. Epub 2019 Jan 22. Leuk Lymphoma. 2019. PMID: 30668190 Free PMC article.
Present and Future in Treatment of Hodgkin Lymphoma.
Turbatu A, Colita A, Bordea AM, Oprea M, Ghimici C, Gelatu I, Ghimfus LA, Stoica AG, Banu CE, Lupu AR. Turbatu A, et al. Maedica (Bucur). 2019 Jun;14(2):144-147. doi: 10.26574/maedica.2019.14.2.144. Maedica (Bucur). 2019. PMID: 31523296 Free PMC article.
Cardiotoxicity of Novel Targeted Hematological Therapies.
Giudice V, Vecchione C, Selleri C. Giudice V, et al. Life (Basel). 2020 Dec 11;10(12):344. doi: 10.3390/life10120344. Life (Basel). 2020. PMID: 33322351 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information